Literature DB >> 9683783

Telomerase activity and telomere lengths in various cell lines: changes of telomerase activity can be another method for chemosensitivity evaluation.

K H Park1, S Y Rha, C H Kim, T S Kim, N C Yoo, J H Kim, J K Roh, S H Noh, J S Min, K S Lee, B S Kim, H C Chung.   

Abstract

For the cancer cells which have overcome the second mitotic clock (M2), activated telomerase is essential and used as another marker of immortality. Many trials had been initiated to target telomerase, which is known to be specific to tumors. To determine the best in vitro cell system for testing the efficacy of telomerase inhibitors, we evaluated the telomerase activity of various cancer cell lines and measured their telomere lengths. We also treated some cancer cell lines with adriamycin and measured the changes of telomerase activity. Telomerase activity was evaluated in various cell lines with the TRAP (telomeric repeat amplification protocol) assay. Telomerase activity was calculated and translated into arbitrary units by computer-assisted densitometry with the control of telomerase activity in the 293 control cell line. Also, terminal restriction fragment lengths were measured using Southern blotting. We also measured telomerase activity and telomere lengths in 11 benign breast tumor tissues and 19 paired stomach cancer and normal tissues. Cancer cell lines treated with adriamycin we evaluated for changes of telomerase activity and the cell proliferation by MTT assay and dye exclusion test. Telomerase activity of cell lines was 95.3 24.1 unit with a range of 27.6-129.6 unit, while the telomere lengths of those cell lines were variable from 5.0 to 10.4 kbp with a median of 6 kbp. In 11 cancer cell lines which were not yet firmly established, we could not detect any telomerase activity. Low telomerase activity was detected in only 2 benign tumor tissues of breast with a median telomere length of 8.8 (7-10.5) kbp. Among paired 19 gastric cancer and normal tissues, only 7 cancer tissues showed weak telomerase activity. After adriamycin treatment, telomerase activity in YCC-S-1, YCC-S-3, MCF-7 and MCF-7/ADR was decreased in accordance with the changes of the cell numbers. Telomerase is specific to cancer tissues and is expressed differently from organ to organ. Telomerase activity by TRAP assay could be used as a chemosensitivity assay.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9683783     DOI: 10.3892/ijo.13.3.489

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  11 in total

1.  Antisense telomerase RNA induced human gastric cancer cell apoptosis.

Authors:  Fang-Xin Zhang; Xue-Yong Zhang; Dai-Ming Fan; Zi-Yun Deng; Yan Yan; Han-Ping Wu; Jun-Jie Fan
Journal:  World J Gastroenterol       Date:  2000-06       Impact factor: 5.742

Review 2.  Unwinding protein complexes in ALTernative telomere maintenance.

Authors:  Saumitri Bhattacharyya; April Sandy; Joanna Groden
Journal:  J Cell Biochem       Date:  2010-01-01       Impact factor: 4.429

3.  Changes in telomerase activity due to alternative splicing of human telomerase reverse transcriptase in colorectal cancer.

Authors:  Hei Cheul Jeung; Sun Young Rha; Sang Joon Shin; Joong Bae Ahn; Kyu Hyun Park; Tae Soo Kim; Jin Ju Kim; Jae Kyung Roh; Hyun Cheol Chung
Journal:  Oncol Lett       Date:  2017-06-21       Impact factor: 2.967

Review 4.  DNA G-quadruplexes, telomere-specific proteins and telomere-associated enzymes as potential targets for new anticancer drugs.

Authors:  E Raymond; J C Soria; E Izbicka; F Boussin; L Hurley; D D Von Hoff
Journal:  Invest New Drugs       Date:  2000-05       Impact factor: 3.850

Review 5.  Methods and goals for the use of in vitro and in vivo chemosensitivity testing.

Authors:  Rosalyn D Blumenthal; David M Goldenberg
Journal:  Mol Biotechnol       Date:  2007-02       Impact factor: 2.695

6.  Inhibition of telomerase by site-specific ribonucleases in gastric and esophageal adenocarcinoma.

Authors:  B Usselmann; D Portsmouth; J Barclay; A G Morris; C U Nwokolo
Journal:  Dig Dis Sci       Date:  2001-12       Impact factor: 3.199

7.  On BLM helicase in recombination-mediated telomere maintenance.

Authors:  Sarallah Rezazadeh
Journal:  Mol Biol Rep       Date:  2012-12-26       Impact factor: 2.316

8.  Telomeric recombination induced by dysfunctional telomeres.

Authors:  Marie Eve Brault; Chantal Autexier
Journal:  Mol Biol Cell       Date:  2010-11-30       Impact factor: 4.138

Review 9.  Human telomerase activity regulation.

Authors:  Aneta Wojtyla; Marta Gladych; Blazej Rubis
Journal:  Mol Biol Rep       Date:  2010-11-18       Impact factor: 2.316

Review 10.  Fundamental mechanisms of telomerase action in yeasts and mammals: understanding telomeres and telomerase in cancer cells.

Authors:  Christine A Armstrong; Kazunori Tomita
Journal:  Open Biol       Date:  2017-03       Impact factor: 6.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.